Scientific Program

Conference Series Ltd invites all the participants across the globe to attend World Cardiology and Cardiologist Meeting Quality Hotel Globe Stockholm, Sweden.

Submit your Abstract
or e-mail to

events@conferenceseries.com
cardiologymeeting@cardiologyconference.org
cardiologymeeting@cardiologyconference.org

Scientific Program Day 1
Scientific Program Day 2

Day 2 :

Keynote Forum

Mikhail Y Rudenko

Russian New University, Russia

Keynote: Cardiometry : A new fundamental scientific field in cardiology
Conference Series Cardiology Meet 2018 International Conference Keynote Speaker Mikhail Y Rudenko photo
Biography:

Rudenko M Yu has been engaged in research in the field of Physiology and Medicine, as well as Medical Equipment Engineering since 1979. From 1980 to 1989, he was engaged in Space Medicine. He has supervised the development of methods and instruments for detecting the psycho-physiological state of spacecraft human operators. In 1990, he has established a private educational institution “The Institute of Chinese medicine”, till 1998, 17 professors of traditional Chinese medicine (TCM) from China worked in this institute. He has excellently mastered the theory and practice of TCM. He wrote several books on TCM and eastern philosophy. He has created an educational course for western doctors. In 1991, he took an active part in foundation of a private educational institution “Russian New University “in Moscow and currently 25000 students study there. At the university, he headed the Scientific School of Hemodynamic Studies of Cardiovascular System. In the process of his research 9 laws of physiology were revealed. He is a member of ESC W.G. on e-cardiology, ID439666. He takes active part in the W.G. conferences and meetings.

 

Abstract:

Aim: The aim of the present study is to expand diagnostics capabilities in Cardiology using the new theory of cardiometry.
 
Materials & Methods: Non-invasive measurement of blood volumes in each cardiac cycle and parameters of cardiac muscle metabolism upon digital processing of an ECG alone allows monitoring of any changes in the cardiovascular system performance. No additional examination is required. The procedure takes only 20 seconds.
 
Conclusions: Using the theory of cardiometry in practice allows you: (1) to determine heart life expectancy in an individual with an accuracy up to several hours; (2) to evaluate efficacy of the selected medication and (3) to effectively use the method in
sports.

Keynote Forum

Samer Ellahham

Cleveland Clinic, United Arab Emirates

Keynote: Heart failure in hemodialysis patients 2018
Biography:

Samer Ellahham has served as Chief Quality Officer and Global Healthcare Leader for SKMC since 2009. He is a Board-certified Internist, Cardiologist and Vascular Medicine Senior Consultant and continues to care for patients. He received his Undergraduate Degree in Biology and his MD from the American University of Beirut,
Beirut, Lebanon. He has obtained his fellowship in Cardiology at the Medical College of Virginia (MCV) in USA. He has worked in Washington DC in several clinical and leadership positions before moving to UAE in 2008. He led the First AHA GWTG Heart Failure Initiative outside US and was the recipient of the AHA GWTG Award in Washington, DC. He is the champion of the AHA GWTG in the region. He continues to be an active Clinician. He is board certified in internal medicine, vascular medicine, Cardiology and quality. He was recently recertified in 2017 by the American Board of Cardiology (ABIM). He is a Fellow of the American College of Cardiology and key member in Heart Failure and Transplant, Adult Congenital and Pediatric Cardiology, Cardio-oncology and
Peripheral Vascular Disease sections.

Abstract:

Patients with end-stage renal disease requiring dialysis are at increased risk for development of heart failure (HF). Factors that may contribute to HF in the dialysis patient include fluid overload, left ventricular diastolic dysfunction, LV systolic dysfunction,
and valvular heart disease. A high-output state caused by shunting through hemodialysis arteriovenous access can also precipitate HF.
 
A proposed functional classification scheme was developed specifically for patients with end-stage renal disease (ESRD) by the Acute Dialysis Quality Initiative (ADQI) XI Workgroup. The cardiac evaluation of dialysis patients should address whether HF is present, what type of HF is present (HFrEF; LVEF ≤40 percent, HF with midrange ejection fraction HFmrEF; LVEF 41 to 50 percent, HF
with preserved ejection fraction HFpEF; LVEF >50 percent, HF from valve disease, and identification of contributing factors. The approach to management of HF in the dialysis patient varies depending on the clinical presentation.